A Plasmodium berghei sporozoite-based vaccination platform against human malaria-Reference-Cited by-同舟云学术

A Plasmodium berghei sporozoite-based vaccination platform against human malaria

Published:2018-08-24 Issue:1 Volume:3 Page:
ISSN:2059-0105
Container-title:npj Vaccines
language:en
Short-container-title:npj Vaccines

Author:

Mendes António M.,Machado Marta,Gonçalves-Rosa Nataniel^ORCID,Reuling Isaie J.^ORCID,Foquet Lander,Marques Cláudia,Salman Ahmed M.,Yang Annie S. P.,Moser Kara A.,Dwivedi Ankit,Hermsen Cornelus C.,Jiménez-Díaz Belén,Viera Sara,Santos Jorge M.^ORCID,Albuquerque Inês,Bhatia Sangeeta N.,Bial John,Angulo-Barturen Iñigo,Silva Joana C.,Leroux-Roels Geert,Janse Chris J.,Khan Shahid M.,Mota Maria M.,Sauerwein Robert W.,Prudêncio Miguel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Link

http://www.nature.com/articles/s41541-018-0068-2.pdf

Reference71 articles.

1. Malaria vaccine: WHO position paper-January 2016. Wkly Epidemiol Rec 91, 33–51 (2016).

2. Prudencio, M., Rodriguez, A. & Mota, M. M. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol 4, 849–856 (2006).

3. Hill, A. V. Vaccines against malaria. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366, 2806–2814 (2011).

4. Gordon, D. M. et al. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J. Infect. Dis. 171, 1576–1585 (1995).

5. Olotu, A. et al. Seven-year efficacy of RTS,S/AS01 malaria vaccine among young African children. N. Engl. J. Med. 374, 2519–2529 (2016).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Toxoplasma gondii secretion systems for intracellular delivery of multiple large therapeutic proteins to neurons;Nature Microbiology;2024-07-29

2. Sporozoite immunization: innovative translational science to support the fight against malaria;Expert Review of Vaccines;2023-08-11

3. Host-parasite interactions during Plasmodium infection: Implications for immunotherapies;Frontiers in Immunology;2023-01-04

4. Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei;Vaccine;2023-01

5. A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria;npj Vaccines;2022-12-16